## Abstract The aim of this study was to evaluate the efficacy and safety of bilateral pallidal (GPi) deep brain stimulation (DBS) 6 months after surgery in advanced parkinsonian patients whose dopa‐resistant axial motor signs or cognitive decline constituted contraindications for subthalamic nucle
Apomorphine infusion in advanced Parkinson’s patients with subthalamic stimulation contraindications
✍ Scribed by Sophie Drapier; Anne-Sophie Gillioz; Emmanuelle Leray; Julie Péron; Tiphaine Rouaud; Annaig Marchand; Marc Vérin
- Book ID
- 116821059
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 135 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Bilateral subthalamic deep brain stimulation (STN‐DBS) and continuous subcutaneous infusion of apomorphine (APM‐csi) can provide a comparable improvement on motor function in patients with advanced Parkinson's disease (PD), but the mechanisms by which both therapies exert their effects
## Abstract Eight patients with advanced PD received a unilateral STN DBS. The UPDRS III __off__ drug–on DBS was improved by a mean 44%. Dyskinesias were ameliorated. Levodopa daily dose was reduced. Three patients required the implantation of the second electrode__.__ Unilateral DBS may be efficac